Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Tenet Healthcare Corporation (THC) vs TransMedics Group Inc (TMDX) Price & Performance

Tenet Healthcare CorporationTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Tenet Healthcare Corporation vs TransMedics Group Inc — how do they compare? Tenet Healthcare Corporation trades at $258.46 (market cap $20.89B), while TransMedics Group Inc trades at $86.5 (market cap $3.10B). The key difference: Tenet Healthcare Corporation is far larger — about 6.7× TransMedics Group Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.

THCTMDX
Market Cap
$20.89B$3.10B
Sector
HealthTechnology
52-Week High
$262.63$150.42
52-Week Low
$161.37$61.99
Enterprise Value
$31.97B$3.49B

Returns comparison

Trailing returns across standard periods

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX